Mineralys Therapeutics To Feature Data From Phase 3 Launch-HTN Trial At ESH 2026
Mineralys Therapeutics Inc MLYS
$30.01
▲ +0.07%
(+$0.02)
Open
$30.32
Prev Close
$29.99
Day Range
$29.40 – $30.42
52W Range
$12.59 – $47.65
Market Cap
$2.48B
Beta
0.44
EPS (TTM)
$-2.06
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2023-02-10 |
| Shares Out. | 82,500,000 |
| Website | mineralystx.com/ ↗ |
| Phone | 18883786240 |
Mineralys Therapeutics Inc is a publicly traded company under the ticker symbol MLYS on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
16 analysts (2026-05-01)